FAK inhibitor

Business news, market intelligence, and global industry analysis.

The Latest

Natural hydrogen exploration gains traction as Benton Resources Inc. stakes six Newfoundland projects with Metals Creek Resources Corp.

Canamera Energy Metals Corp. tests third ionic clay REE asset as Brazil strategy deepens (OTCQB: EMETF)

Representative image of enterprise AI agent security, highlighting how RSA Security’s Microsoft partnership aims to protect autonomous software identities from emerging authentication and access threats.

Can RSA’s Microsoft partnership protect enterprise AI agents from the identity threats no one saw coming?

Arm Holdings breaks 35-year model with first data center chip, backed by Meta and OpenAI

Arm Holdings launches first in-house data center CPU in historic company pivot targeting agentic AI infrastructure

Amplia Therapeutics (ASX:ATX) reports five complete responses and improved survival in ACCENT pancreatic cancer trial

Amplia Therapeutics (ASX:ATX) posts 7.8% complete response rate and 11.1-month mOS in ACCENT pancreatic cancer trial. Read the full strategic analysis.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

March 23, 2026